Vulnerabilities

Vulnerability · CVE-2019-10201

It was found that Keycloak's SAML broker, versions up to 6.0.1, did not verify missing message signatures.

Published Aug 14, 2019 · catalog updated Jun 17, 2026 · It was found that

Last checked Nov 6, 2026. A connected source was read within the last 7 days.

Check if you run it

No confirmed exploitation is on record for CVE-2019-10201. EPSS is 0.71%. Act only if a listed version of It was found that is installed.

Gaps on this record

  • The stored product name is a package slug. The name on this page is taken from the title (It was found that).
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.

Same product and reporting

Severity
High8.1
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.71%
Remediation
Version ranges on file
Affected products
cpe redhat/keycloak · cpe redhat/single sign-on

It was found that Keycloak's SAML broker, versions up to 6.0.1, did not verify missing message signatures. If an attacker modifies the SAML Response and removes the sections, the message is still accepted, and the message can be modified. An attacker could use this flaw to impersonate other users and gain access to sensitive information.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • cpe redhat/keycloak<= 6.0.1
  • cpe redhat/single sign-on7.0
  • cpe redhat/single sign-on7.3.3

How to fix CVE-2019-10201

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2019-10201. EPSS is 0.71%. Act only if a listed version of It was found that is installed.

Which versions are affected?

Compare what you have installed with redhat/single sign-on 7.0; redhat/single sign-on 7.3.3. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-347: Improper Verification of Cryptographic Signature; CWE-592. EPSS 0.71%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Technology hubs

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Aug 14, 2019 · Monitored products — high

    Detected

    It was found that Keycloak's SAML broker, versions up to 6.0.1, did not verify missing message signatures. If an attacker modifies the SAML Response and removes the sections, the message is still accepted, and the message can be modified. An attacker could use this flaw to impersonate other users and gain access to sensitive information.

  2. Jun 17, 2026 · Monitored products — high

    Updated

    It was found that Keycloak's SAML broker, versions up to 6.0.1, did not verify missing message signatures. If an attacker modifies the SAML Response and removes the sections, the message is still accepted, and the message can be modified. An attacker could use this flaw to impersonate other users and gain access to sensitive information.

Sources

  • CVE.orgVulnerability recordCVE-2019-10201

    Official CVE identifier

    cve.org
  • Monitored products — highVendor advisoryCVE-2019-10201

    It was found that Keycloak's SAML broker, versions up to 6.0.1, did not verify missing message signatures. If an attacker modifies the SAML Response and removes the sections, the message is still accepted, and the message can be modified. An attacker could use this flaw to impersonate other users and gain access to sensitive information.

    nvd.nist.gov

References

Freshness

Last verified in this catalog Nov 6, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.

  • CVE.orgNov 4, 2026
  • Monitored products — highNov 3, 2026